BHV-2100, a First-in-Class TRPM3 Antagonist in Development for the Treatment of Migraine (P7-12.009)
用户XhVHxr2vpUxk
1小时前
20
10
已关闭
DOI: 10.1212/wnl.0000000000211319
文献链接: https://www.neurology.org/doi/10.1212/WNL.0000000000211319
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Beth Emerson; Anne Pieters; Beth Morris; Andrew Lucas; Volkan Granit; Christopher Jensen; Joris Vriens; Thomas Voets; Irfan Qureshi; Vladimir Coric; Richard Lipton

